Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 15,363	$ 16,557
Accounts receivable, net of allowance for credit losses of $542 and $3,322, respectively	16,895	13,973
Inventory	8,101	6,493
Prepaid expenses and other current assets	2,171	2,921
Total current assets	42,530	39,944
Property and equipment, net	193	377
Right of use assets, net	217	937
Intangible assets, net	2,224	2,210
Other assets	731	655
Total assets	45,895	44,123
Current liabilities:
Accounts payable	17,510	13,679
Accrued and other expenses	11,550	15,051
Current portion of deferred revenues	1,242	1,166
Line of credit	9,738	9,250
Current portion of long-term and other debt	2,110	5,944
Total current liabilities	42,150	45,090
Common stock warrant liabilities	24,429	27,781
Other long-term liabilities	150	928
Total liabilities	66,729	73,799
Commitments and Contingencies
Stockholders’ deficit:
Common stock, $0.0001 par value, 107,142,857 shares authorized as of June 30, 2024 and December 31, 2023; 9,099,539 and 8,797,456 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively.	1	1
Additional paid-in capital	220,102	218,127
Accumulated deficit	(253,532)	(255,659)
Total stockholders’ deficit	(33,429)	(37,531)
Total liabilities, convertible preferred stock, and stockholders’ deficit	45,895	44,123
Series A Convertible Preferred Stock
Current liabilities:
Convertible preferred stock	9,839	7,855
Series B Convertible Preferred Stock
Current liabilities:
Convertible preferred stock	$ 2,756	$ 0